Join to View Full Profile
1275 York AvenueNew York, NY 10065
Are you Dr. Elenitoba-Johnson?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Kojo Elenitoba-Johnson, MD is a board certified pathologist in New York, New York. He is currently licensed to practice medicine in New York and Pennsylvania. He is a Professor at University of Michigan Medical School.
Education & Training
Rhode Island Hospital/Brown University HealthResidency, Pathology-Anatomic and Clinical, 1991 - 1995
University of Lagos College of MedicineClass of 1988
Certifications & Licensure
NY State Medical License 2022 - 2025
PA State Medical License 2015 - 2022
American Board of Pathology Anatomic Pathology & Clinical Pathology- American Board of Pathology Hematology
- American Board of Pathology Molecular Genetic Pathology
Publications & Presentations
PubMed
- The FBXO45-GEF-H1 Axis Controls Germinal Center Formation and B-cell Lymphomagenesis.Anagh A Sahasrabuddhe, Xiaofei Chen, Kaiyu Ma, Rui Wu, Huan-Chang Liang
Cancer Discovery. 2025-04-02 - HLA-I aberrations in cutaneous T-cell lymphoma.Ting Zhou, Kojo S J Elenitoba-Johnson
Blood. 2025-01-16 - 1 citationsHigh-resolution melting assay for rapid, simultaneous detection of,andvariants.Christopher M Sande, Guang Yang, Ayman Mohamed, Ben L Legendre, Danielle Pion
Journal of Clinical Pathology. 2024-08-16
Press Mentions
Association for Molecular Pathology Announces 2018 Award RecipientsAugust 22nd, 2018
This Last-Resort Test Saved 2 Women from Cancer—and It Could Save You, TooAugust 29th, 2017
New Study Discovers "Killer Peptide" That Helps Eliminate Resistant Cancer CellsAugust 19th, 2017
Grant Support
- Genomic biomarkers of splenic lymphomaSLOAN-KETTERING INST CAN RESEARCH2022–2025
- Epiproteomics of Sezary SyndromeSLOAN-KETTERING INST CAN RESEARCH2020–2025
